Examkin

Preventive Care and Immunizations

105 questions

All types105Multiple choice54Matching24Ordering27
Question 81Question →

Match each pediatric patient presenting for a routine well-child visit with the age-appropriate universal screening intervention recommended by the American Academy of Pediatrics (AAP), regardless of their individual risk factors.

Click a left item, then click its matching right item

Items

A 24-month-old boy with a vocabulary of 50 words and normal interactive play
A 3-year-old girl with no significant medical history who is fully toilet trained
An 11-year-old boy who plays competitive sports and has a normal BMI
A 16-year-old girl who denies sexual activity and has no history of substance use

Matches

Show answer & explanation

Answer

The correct matches pair the 24-month-old with the autism-specific questionnaire, the 3-year-old with annual blood pressure measurement, the 11-year-old with a lipid profile, and the 16-year-old with HIV screening.
Each age group corresponds to a specific universal screening requirement according to AAP preventive care guidelines. At 24 months, toddlers receive their second universal screening for autism. At 3 years of age, routine annual blood pressure measurement begins. Between 9 and 11 years (e.g., age 11), children undergo universal lipid screening. Finally, adolescents between the ages of 15 and 18 (e.g., age 16) should universally undergo screening for HIV.

Step-by-Step Solution

1
Determine the universal screening requirement for the 24-month-old patient.
Administration of a standardized autism-specific questionnaire.
The AAP recommends formal autism screening with a standardized tool (such as the M-CHAT) for all children at 18 and 24 months of age, regardless of perceived developmental progress.
2
Determine the universal screening requirement for the 3-year-old patient.
Initiation of universal annual blood pressure measurement.
Routine, universal blood pressure measurement begins at 3 years of age. Children younger than 3 only require blood pressure monitoring if they have specific risk factors (e.g., congenital heart disease, renal disease, history of prematurity).
3
Determine the universal screening requirement for the 11-year-old patient.
Measurement of a non-fasting lipid profile.
Universal screening for dyslipidemia should be performed once between the ages of 9 and 11 years, even in active children with a normal BMI and no family history.
4
Determine the universal screening requirement for the 16-year-old patient.
Universal screening for human immunodeficiency virus (HIV) infection.
The AAP recommends universal HIV screening at least once for all adolescents between the ages of 15 and 18 years, regardless of reported sexual activity or drug use.

Key Concept

Age-appropriate universal screening guidelines for pediatric health maintenance visits.
Question 82Question →

An 18-month-old boy is brought to the pediatrician for a well-child visit and vaccination update. He was diagnosed with minimal change disease one month ago and has been taking oral prednisone at a dose of 2 mg/kg/day since the diagnosis. His parents report that he is doing well overall and his edema has resolved. They are concerned about his development, noting that while he can walk backward, scribble with crayons, and use about 15 individual words, he cannot yet jump with both feet or use two-word phrases. The patient missed his 12-month and 15-month appointments and has not received any immunizations since 6 months of age. Vital signs are within normal limits. Physical examination reveals a playful child with a cushingoid appearance but no peripheral edema. Which of the following is the most appropriate management regarding his immunizations and development?

Show answer & explanation

Answer: Administer age-appropriate inactivated vaccines, defer live-attenuated vaccines, and reassure the parents regarding his development

Answer

Administer age-appropriate inactivated vaccines, defer live-attenuated vaccines, and reassure the parents regarding his development
The correct management is to administer inactivated vaccines, defer live-attenuated vaccines, and reassure the parents. This patient is receiving high-dose systemic corticosteroids (defined as ≥2 mg/kg/day or ≥20 mg/day of prednisone or its equivalent for 14 or more consecutive days). This level of therapy induces profound immunosuppression. Consequently, live-attenuated vaccines (such as MMR and Varicella, which he missed at 12 and 15 months) are strictly contraindicated due to the risk of uncontrolled vaccine-strain infection, and must be deferred until at least one month after steroid discontinuation. However, inactivated vaccines (such as DTaP, IPV, Hib, PCV15, and HepA) are entirely safe for immunocompromised patients and should be administered immediately to provide critical protection. Developmentally, the child is perfectly on track for an 18-month-old: he can walk backwards, scribble, and has a typical vocabulary of about 15 words. His parents' concerns involve milestones expected at 24 months (jumping with both feet, two-word phrases), so reassurance is the only developmental intervention required.

Step-by-Step Solution

1
Evaluate the patient's medication list for contraindications to immunizations.
The patient is on high-dose systemic corticosteroids (2 mg/kg/day for 4 weeks), which causes significant immunosuppression.
Immunosuppression dictates which vaccines can be safely administered.
2
Determine the appropriate vaccine administration plan based on immune status.
Live-attenuated vaccines (e.g., MMR, varicella) must be deferred, while inactivated vaccines (e.g., DTaP, Hib, PCV, HepA) are safe and should be given to catch the patient up.
Live vaccines carry a risk of vaccine-strain disseminated infection in immunocompromised hosts, but inactivated vaccines carry no such risk.
3
Assess the patient's developmental milestones against standardized age expectations.
Walking backward, scribbling, and a 15-word vocabulary are normal for 18 months. Jumping and two-word phrases are 24-month milestones.
Accurate milestone tracking prevents unnecessary referrals and provides appropriate parental reassurance.

Key Concept

Live vaccines are contraindicated in patients on high-dose corticosteroids, but inactivated vaccines should be given; 18-month milestones include walking backwards, 10-25 words, and scribbling.
Question 83Question →

A medical student is reviewing developmental screening tools used during routine well-child preventive care visits. To correctly administer screening questionnaires and identify potential delays, the student must know the normal progression of infant and toddler development. Arrange the following fine motor milestones in the chronological order in which they are typically achieved by a healthy neurotypical child, from earliest to latest.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological order is: Brings both hands together at the midline (3-4 months), Transfers an object from one hand to the other (6 months), Demonstrates a mature pincer grasp (10-12 months), Builds a vertical tower of six consecutive cubes (24 months), and Successfully copies a drawn circle (36 months).
The normal chronological progression of these fine motor milestones reflects the proximal-to-distal development of the pediatric nervous system. An infant first establishes shoulder and arm control to bring hands to the midline (3-4 months). Next, they learn to transfer objects between hands (6 months). By 10-12 months, the infant develops a mature pincer grasp for small objects. Complex multi-step tasks like building a tower of six cubes are achieved at 24 months, and advanced visual-motor integration skills like copying a circle emerge at 36 months.

Step-by-Step Solution

1
Determine the typical age of onset for bringing hands to the midline.
This occurs at 3 to 4 months of age.
This is one of the earliest voluntary bilateral fine motor coordinations observed in infants.
2
Determine the typical age of onset for transferring an object between hands.
This occurs at 6 months of age.
It requires the developmental progression to voluntarily grasp and release an object.
3
Determine the typical age of onset for a mature pincer grasp.
This occurs at 10 to 12 months of age.
It marks the transition from a gross palmar grasp to precise distal finger coordination.
4
Determine the typical age of onset for building a tower of six cubes.
This occurs at 24 months (2 years) of age.
It demonstrates improved visual-spatial awareness and highly precise object release (compared to a 2-cube tower at 15 months).
5
Determine the typical age of onset for copying a drawn circle.
This occurs at 36 months (3 years) of age.
It requires advanced visual-motor integration, preceding copying a cross (4 years) or a square (4.5 years).

Key Concept

The chronological sequence of fine motor milestones during pediatric well-child developmental screening.
Estimated Time:1m 0s
Question 84Question →

A 5-year-old girl presents to the clinic with her adoptive parents for an initial health assessment. The family recently immigrated, and the parents state that the child has no previous medical or vaccination records. The patient's past medical history is notable for severe persistent asthma. Three weeks prior to her arrival, she suffered a severe asthma exacerbation that required a pediatric intensive care unit admission. She was discharged on a regimen of oral prednisone 2 mg/kg daily, which she has continued taking for the past 21 days. Her other medications include high-dose inhaled fluticasone and as-needed albuterol. Vital signs are within normal limits. Physical examination reveals cushingoid features but is otherwise unremarkable, with clear breath sounds bilaterally. The physician is planning her catch-up immunization schedule. Which of the following is the most appropriate immunization management for this patient at today's visit?

Show answer & explanation

Answer: Administer DTaP, inactivated poliovirus, and hepatitis B vaccines; defer all live-attenuated vaccines

Answer

Administer DTaP, inactivated poliovirus, and hepatitis B vaccines; defer all live-attenuated vaccines
The correct management is to administer age-appropriate inactivated vaccines while deferring all live-attenuated vaccines. This 5-year-old patient has an undocumented immunization status and must initiate the catch-up schedule. She is currently taking high-dose oral prednisone (2 mg/kg/day for 21 days). Systemic corticosteroid therapy is considered severely immunosuppressive when administered at doses of ≥2 mg/kg/day or ≥20 mg/day for ≥14 consecutive days. In such patients, live-attenuated vaccines (e.g., MMR, varicella, live-attenuated intranasal influenza) are strictly contraindicated due to the risk of uncontrolled vaccine-strain viral replication and disseminated infection. These live vaccines must be deferred until at least 4 weeks after the high-dose corticosteroids have been discontinued. Conversely, inactivated vaccines (such as DTaP, IPV, and hepatitis B) carry no risk of vaccine-strain infection and are safe to administer to immunocompromised hosts. Furthermore, because the patient is 5 years old, DTaP is the correct pertussis-containing formulation, as Tdap is reserved for children 7 years of age and older.

Step-by-Step Solution

1
Determine the patient's baseline immunization needs.
As an international adoptee with no immunization records, the patient is considered unimmunized and requires a full catch-up schedule.
Undocumented vaccines cannot be assumed to have been administered.
2
Assess the patient's current immune status based on her medication history.
The patient is taking oral prednisone at 2 mg/kg/day for 21 days, which constitutes severe immunosuppression.
Corticosteroid doses of ≥2 mg/kg/day or ≥20 mg/day for ≥14 days cause clinically significant immunosuppression.
3
Apply vaccine guidelines for severely immunocompromised patients.
Live-attenuated vaccines (e.g., MMR, varicella) are contraindicated and must be deferred. Inactivated vaccines (e.g., DTaP, IPV, hepatitis B) are safe to administer.
Live vaccines pose a risk of vaccine-strain viral replication and disseminated infection in immunocompromised hosts, whereas inactivated vaccines pose no such risk.
4
Select the appropriate vaccine formulations based on the patient's age.
The patient is 5 years old, so she should receive DTaP rather than Tdap.
DTaP is indicated for children under 7 years of age, while Tdap is indicated for individuals 7 years and older.

Key Concept

In patients receiving high-dose systemic corticosteroids (≥2 mg/kg/day or ≥20 mg/day of prednisone for ≥14 days), live-attenuated vaccines are strictly contraindicated until at least 4 weeks after discontinuation, whereas inactivated vaccines can be safely administered on schedule.
Question 85Question →

A 2-month-old boy is brought to the clinic for a routine well-child visit. He was born at 39 weeks gestation via an uncomplicated vaginal delivery. His mother has a history of severe Crohn's disease that was well controlled during pregnancy with intravenous infliximab. She received her last infusion of infliximab at 35 weeks gestation. The infant is exclusively breastfed and is gaining weight appropriately. His vital signs and physical examination are unremarkable. The mother asks about the infant's scheduled 2-month immunizations, which typically include the diphtheria, tetanus, and acellular pertussis (DTaP); Haemophilus influenzae type b (Hib); inactivated poliovirus (IPV); pneumococcal conjugate (PCV); and rotavirus vaccines. Which of the following is the most appropriate immunization plan for this patient today?

Show answer & explanation

Answer: Administer DTaP, Hib, IPV, and PCV, but withhold the rotavirus vaccine

Answer

Administer DTaP, Hib, IPV, and PCV, but withhold the rotavirus vaccine
This infant requires modification of the routine 2-month immunization schedule due to in utero exposure to infliximab. Infliximab is an IgG monoclonal antibody targeting TNF-alpha. During the third trimester, maternal IgG is actively transported across the placenta to provide passive immunity to the fetus. As a result, therapeutic biologics also cross the placenta, leading to clinically significant drug levels in the newborn that can persist for up to 6 months. Therefore, this infant is considered functionally immunocompromised. The rotavirus vaccine is a live-attenuated oral vaccine and is strictly contraindicated in immunocompromised infants due to the risk of severe, vaccine-strain disseminated infection. In contrast, all inactivated vaccines (such as DTaP, Hib, IPV, and PCV) are safe, incapable of causing infection, and should be administered according to the normal chronological schedule to ensure the infant is protected.

Step-by-Step Solution

1
Identify the patient's immune status based on maternal medication history.
The infant is considered transiently immunocompromised due to in utero exposure to infliximab (a TNF-alpha inhibitor) during the third trimester.
Biologic therapies like infliximab are IgG antibodies that actively cross the placenta and can persist in the infant's circulation for the first 6 months of life.
2
Determine the safety profile of the scheduled 2-month vaccines for an immunocompromised infant.
Inactivated vaccines (DTaP, Hib, IPV, PCV) are safe, whereas live-attenuated vaccines (rotavirus) are strictly contraindicated.
Live-attenuated vaccines can cause uncontrolled, severe disseminated infection in hosts with compromised cellular immunity.
3
Formulate the correct immunization plan.
Proceed with all routine inactivated vaccines but withhold the rotavirus vaccine.
This protects the infant against preventable illnesses without risking vaccine-induced disease.

Key Concept

Infants born to mothers receiving biologic therapies (e.g., TNF-alpha inhibitors) during the third trimester are considered immunocompromised for the first 6 months of life and must not receive live-attenuated vaccines, such as the rotavirus vaccine.
Question 86Question →

Match each high-risk pediatric patient presentation with the most appropriate specific preventive care or immunization intervention.

Click a left item, then click its matching right item

Items

A 2-year-old child with sickle cell anemia presenting for a well-child visit
A 4-month-old infant born at 28 weeks gestation presenting at the onset of the winter season
A 12-month-old child with severe combined immunodeficiency (SCID) presenting for routine immunizations
A 6-year-old child with severe persistent asthma and a recent history of wheezing

Matches

Show answer & explanation

Answer

The correct matches align each specific high-risk pediatric condition with its indicated modification to the standard immunization and preventive care schedule.
Each pairing correctly identifies the specific preventive care modification required for the patient's underlying condition: PPSV23 for functional asplenia at age 2, RSV prophylaxis for extreme prematurity, avoidance of live vaccines for severe cellular immunodeficiencies, and mandatory selection of inactivated (rather than live-attenuated) influenza vaccine for patients with severe asthma or recent wheezing.

Step-by-Step Solution

1
Evaluate the 2-year-old with sickle cell anemia.
Matches with administration of PPSV23.
Functional asplenia increases the risk of invasive pneumococcal disease, necessitating PPSV23 at age 2.
2
Evaluate the 4-month-old premature infant.
Matches with RSV prophylaxis.
Prematurity increases vulnerability to severe RSV disease during the winter season.
3
Evaluate the 12-month-old with SCID.
Matches with absolute contraindication to live vaccines.
Profound T-cell defects allow live vaccine strains (like MMR/Varicella due at 12 months) to cause uncontrolled, fatal infections.
4
Evaluate the 6-year-old with severe asthma.
Matches with inactivated influenza vaccine administration.
Live-attenuated influenza vaccine can trigger exacerbations in children with severe asthma or recent wheezing, requiring the inactivated form.

Key Concept

Immunization and preventive care modifications in high-risk pediatric populations (asplenia, prematurity, immunodeficiency, chronic pulmonary disease).
Question 87Question →

A toddler is evaluated at the pediatric clinic for a health maintenance visit at 15 months of age. His mother reports that he has been doing well since a hospitalization 5 months ago. At that time, he presented with 6 days of high fever, bilateral nonexudative conjunctivitis, erythema of the oral mucosa, and a generalized maculopapular rash. He was successfully treated in the hospital and discharged home. The patient currently takes daily low-dose aspirin and has no other medical conditions. He previously received all routine immunizations up to 6 months of age, but has not received any vaccines since then. His temperature is 37.1 C (98.8 F), blood pressure is 90/55 mm Hg, pulse is 110/min, and respirations are 24/min. Physical examination today is unremarkable. Which of the following is the most appropriate immunization plan for this patient today?

Show answer & explanation

Answer: Administer DTaP, Haemophilus influenzae type b, pneumococcal conjugate, and hepatitis A vaccines; defer measles-mumps-rubella and varicella vaccines.

Answer

Administer DTaP, Haemophilus influenzae type b, pneumococcal conjugate, and hepatitis A vaccines; defer measles-mumps-rubella and varicella vaccines.
This patient's clinical presentation of prolonged high fever, bilateral nonexudative conjunctivitis, erythema of the oral mucosa, and a polymorphic rash indicates a history of Kawasaki disease. The standard treatment for Kawasaki disease is intravenous immunoglobulin (IVIG) and high-dose aspirin. IVIG contains pooled exogenous IgG antibodies that can bind and neutralize the viruses in live-attenuated vaccines, such as the measles-mumps-rubella (MMR) and varicella vaccines, leading to an inadequate immune response. Because the standard dose of IVIG for Kawasaki disease (2 g/kg) provides high levels of circulating antibodies, live-attenuated vaccines must be deferred for exactly 11 months following treatment. Therefore, at 5 months post-treatment, this patient should not receive the MMR and varicella vaccines. However, inactivated vaccines (DTaP, Haemophilus influenzae type b, pneumococcal conjugate, and hepatitis A) are not affected by circulating exogenous antibodies and should be administered according to the routine catch-up schedule.

Step-by-Step Solution

1
Diagnose the patient's past illness based on the clinical presentation described.
The history of prolonged high fever, bilateral nonexudative conjunctivitis, mucosal changes, and rash indicates Kawasaki disease.
Identifying the disease is necessary to determine the medical treatment he received 5 months ago.
2
Identify the standard treatment administered for Kawasaki disease.
The patient was treated with intravenous immunoglobulin (IVIG) and high-dose aspirin.
Vaccine scheduling is directly impacted by recent administration of blood products like IVIG.
3
Evaluate the effect of recent IVIG on the routine 15-month immunization schedule.
IVIG contains exogenous antibodies that neutralize live-attenuated viral vaccines (MMR and varicella) for up to 11 months. Inactivated vaccines are unaffected.
This determines which vaccines are safe and effective to give today versus which must be delayed.
4
Select the appropriate vaccines to administer and defer.
Administer the overdue inactivated vaccines (DTaP, Hib, PCV, HepA) and defer the live-attenuated vaccines (MMR, varicella) until 11 months post-IVIG.
This strategy maximizes protection against preventable diseases while avoiding ineffective vaccination.

Key Concept

Live-attenuated vaccines must be deferred for up to 11 months following administration of high-dose intravenous immunoglobulin (IVIG) to prevent neutralization by exogenous antibodies, whereas inactivated vaccines can be administered on their normal schedule.
Question 88Question →

Match each pediatric patient scenario involving an infectious exposure or specific risk factor with the most appropriate immediate preventive care intervention or post-exposure prophylaxis.

Click a left item, then click its matching right item

Items

A 9-month-old healthy infant scheduled to travel to a measles-endemic country in 2 weeks.
A 2-day-old neonate whose mother developed a diffuse vesicular rash 24 hours prior to delivery.
A 4-month-old infant whose 6-year-old sibling was recently diagnosed with culture-positive pertussis.
An unimmunized 8-year-old boy who sustained a deep, soil-contaminated puncture wound to the foot.
A 12-hour-old preterm neonate (birth weight 1,800 g) born to a mother with undocumented HBsAg status.

Matches

Show answer & explanation

Answer

The correct matches align specific post-exposure and travel scenarios with their respective, time-sensitive immunoprophylaxis and chemoprophylaxis guidelines.
Appropriate preventive care requires tailoring interventions strictly to the clinical scenario. Early MMR protects young travelers but must be repeated later. VZIG provides critical passive immunity when maternal varicella occurs peripartum. Macrolide prophylaxis halts pertussis transmission in households. Tetanus prophylaxis for dirty wounds in unimmunized patients requires both TIG and a vaccine (Tdap for >7 years). Preterm infants (<2,000 g) with unknown maternal HBsAg need both HepB vaccine and HBIG immediately due to their blunted immune response.

Step-by-Step Solution

1
Analyze the 9-month-old traveler scenario.
Identify need for early MMR.
Measles is highly contagious and endemic in many countries; infants 6-11 months require an early protective dose that does not count toward the routine series.
2
Evaluate the perinatal varicella exposure.
Select VZIG.
Maternal rash onset 5 days before to 2 days after delivery leaves the neonate without protective IgG, mandating immediate passive immunization.
3
Assess the pertussis contact.
Select azithromycin prophylaxis.
Household contacts require macrolide prophylaxis to prevent transmission, independent of their vaccination status.
4
Determine tetanus prophylaxis for the 8-year-old with a dirty wound.
Select Tdap and TIG.
Unknown or incomplete immunization with a dirty wound requires both active and passive immunity. Tdap is indicated for children aged 7 and older.
5
Determine HepB management for the preterm neonate.
Select HepB vaccine and HBIG within 12 hours.
Infants <2,000 g with unknown maternal HBsAg status require both interventions immediately due to their immature immune response.

Key Concept

Post-exposure prophylaxis and specialized catch-up/travel immunizations require precise application of guidelines based on patient age, weight, and the exact timing and nature of the exposure.
Question 89Question →

A mother brings her 12-month-old son to the pediatrician for a scheduled health maintenance examination. He underwent a hepatic transplantation at 8 months of age due to biliary atresia and is currently maintained on an immunosuppressive regimen of oral tacrolimus and mycophenolate mofetil. His vital signs are within normal limits, and the physical examination is unremarkable. His mother reports that he is able to pull himself up to a standing position and cruise along furniture, but she expresses concern because he is not yet walking independently. He uses a neat pincer grasp to eat small pieces of food and speaks three specific words: "mama," "dada," and "ball." Medical records indicate he received all routine childhood immunizations precisely on schedule through his 6-month visit. Which of the following is the most appropriate management regarding this patient's care today?

Show answer & explanation

Answer: Provide only the indicated inactivated vaccines, delay live-attenuated vaccines, and reassure the mother regarding his development

Answer

The most appropriate management is to provide only the indicated inactivated vaccines, delay live-attenuated vaccines, and reassure the mother regarding his normal development.
The correct approach is to provide the indicated inactivated vaccines while delaying live-attenuated vaccines, and to reassure the mother. Patients who have undergone solid organ transplantation and are on active immunosuppressive therapy (e.g., tacrolimus, mycophenolate mofetil) have significant cellular immune deficits. Therefore, live-attenuated vaccines (such as the Measles-Mumps-Rubella [MMR] and Varicella vaccines, which are routinely given at 12 months of age) are strictly contraindicated due to the risk of uncontrolled, disseminated vaccine-strain infection. However, inactivated vaccines (such as the pneumococcal conjugate, Haemophilus influenzae type b, and inactivated polio vaccines) remain safe and are strongly recommended to protect these vulnerable patients from significant morbidity, even if their resulting immunogenicity may be slightly blunted. Developmentally, cruising (walking while holding onto furniture) is the expected gross motor milestone for a 12-month-old. Independent walking is achieved by most children by 15 months of age, meaning this child's gross motor development is completely normal and requires parental reassurance rather than a referral.

Step-by-Step Solution

1
Evaluate the child's developmental milestones based on his chronological age of 12 months.
Cruising along furniture is an age-appropriate gross motor skill. Independent walking is typically expected between 12 and 15 months.
To address the mother's concern and determine if a developmental referral is medically necessary.
2
Assess the patient's immune status based on his medical history and current medications.
The patient is on a maintenance immunosuppressive regimen (tacrolimus and mycophenolate mofetil) following a solid organ transplant, rendering him severely immunocompromised.
To determine whether standard vaccine protocols apply or if modifications are required.
3
Apply immunization guidelines for severely immunocompromised pediatric patients.
Live-attenuated vaccines (e.g., MMR, Varicella) are absolutely contraindicated, while age-appropriate inactivated vaccines (e.g., PCV, Hib) remain safe and must be administered.
To formulate a safe and effective preventive care plan for this clinic visit.

Key Concept

Live-attenuated vaccines are contraindicated in patients on systemic immunosuppressive therapy due to the risk of severe infection, while inactivated vaccines remain safe and should be administered. Furthermore, cruising along furniture is normal at 12 months; independent walking is not strictly expected until 15 months.
Estimated Time:1m 30s
Question 90Question →

A pediatric clinic is updating its health maintenance protocols to align with the latest American Academy of Pediatrics (AAP) and Centers for Disease Control and Prevention (CDC) guidelines. The clinic director is reviewing the timeline of universal preventive care interventions for healthy, full-term pediatric patients with no significant family history of disease. Arrange the following routine preventive care interventions in chronological order, starting with the intervention recommended at the earliest age.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence is: administration of the first dose of rotavirus vaccine (2 months), universal screening for iron deficiency anemia (12 months), universal screening for autism spectrum disorder (18 months), universal screening for dyslipidemia (9 to 11 years), and universal screening for major depressive disorder (12 years).
The correct chronological sequence aligns with the AAP periodicity schedule for pediatric health maintenance. The rotavirus vaccine is initiated at 2 months. Universal screening for anemia is performed at 12 months. Universal screening for autism spectrum disorder is performed at 18 (and 24) months. Universal lipid screening is conducted once between 9 and 11 years of age. Finally, universal screening for major depressive disorder begins at 12 years of age.

Step-by-Step Solution

1
Determine the recommended age for the first dose of the rotavirus vaccine.
It is recommended at 2 months of age.
Rotavirus is a live-attenuated vaccine that has a strict upper age limit for initiation (14 weeks, 6 days) and is routinely started at the 2-month well-child visit.
2
Determine the recommended age for universal iron deficiency anemia screening.
It is recommended at 12 months of age.
Dietary iron stores from birth become depleted by 6 months, and the transition to whole cow's milk at 12 months increases the risk of iron deficiency, making this the optimal time for universal screening.
3
Determine the recommended age for universal autism spectrum disorder screening.
It is recommended at 18 and 24 months of age.
Symptoms of autism spectrum disorder often become most clearly identifiable in the second year of life, prompting targeted universal screening at these specific visits.
4
Determine the recommended age for universal dyslipidemia screening.
It is recommended between 9 and 11 years of age.
Universal screening is recommended prior to the onset of puberty (which can transiently lower lipid levels) to identify familial hypercholesterolemia and other lipid disorders.
5
Determine the recommended age for universal major depressive disorder screening.
It is recommended starting at 12 years of age.
The incidence of adolescent depression increases significantly around this age, making annual universal screening starting at 12 years a standard of care.

Key Concept

Routine pediatric preventive care follows a specific age-based timeline for immunizations and universal screenings to detect physical, developmental, and psychological conditions early.
Estimated Time:1m 0s
Question 91Question →

A 4-year-old girl is brought to the pediatric clinic for a routine well-child visit. She has a history of perinatally acquired HIV infection. Her mother admits they have struggled with adherence to her antiretroviral therapy regimen over the past year. Her most recent laboratory studies from two weeks ago show an HIV viral load of 150,000 copies/mL and a CD4 T-lymphocyte count of 250 cells/mm³ (CD4 percentage of 11%). She recently recovered from a mild upper respiratory tract infection but has no symptoms today. Vital signs are within normal limits for her age. Review of her immunization record indicates she received all age-appropriate vaccines during infancy and toddlerhood, but she is currently due for her 4-year preschool boosters. During the physical examination, the girl is observed hopping on one foot and successfully copying a cross drawn by the physician. Her mother notes that she frequently engages in cooperative play with other children at daycare. Which of the following is the most appropriate plan for this patient today?

Show answer & explanation

Answer: Administer DTaP and IPV, but withhold MMR and varicella vaccines; development is age-appropriate

Answer

Administer DTaP and IPV, but withhold MMR and varicella vaccines; development is age-appropriate
The correct approach involves accurately assessing both the patient's developmental milestones and her immunization eligibility given her HIV status. For a 4-year-old child, normal developmental milestones include hopping on one foot (gross motor), copying a cross (fine motor), and engaging in cooperative play (social). Because this patient exhibits these skills, her development is completely age-appropriate, and no neurodevelopmental referral is indicated. Regarding immunizations, children at age 4 are due for their preschool boosters: DTaP, IPV, MMR, and varicella. While inactivated vaccines (such as DTaP and IPV) are safe and recommended for all HIV-infected children regardless of their immune status, live-attenuated vaccines (MMR, varicella) carry a severe risk of disseminated infection in immunocompromised hosts. According to CDC guidelines, severe immunosuppression in children aged 1 to 5 years is defined as a CD4 count <500 cells/mm³ or a CD4 percentage <15%. This patient's CD4 count of 250 cells/mm³ and CD4% of 11% firmly place her in the severely immunosuppressed category, making the live-attenuated MMR and varicella vaccines strictly contraindicated today.

Step-by-Step Solution

1
Evaluate the patient's developmental milestones based on the physical exam findings.
Hopping on one foot (gross motor), copying a cross (fine motor), and playing cooperatively (social) are all normal, age-appropriate milestones for a 4-year-old child.
To determine if a neurodevelopmental referral is indicated or if the parents can be reassured.
2
Identify the routine immunizations due for a 4-year-old child.
The standard preschool booster vaccines required at age 4 include DTaP, IPV, MMR, and varicella.
To establish the baseline immunization needs before applying patient-specific contraindications.
3
Assess the patient's immune status based on her age and HIV laboratory results.
For a child aged 1 to 5 years, a CD4 count <500 cells/mm³ or a CD4 percentage <15% defines severe immunosuppression. The patient's CD4 count of 250 cells/mm³ (11%) meets these criteria.
To determine if live-attenuated vaccines are safe to administer.
4
Synthesize findings to formulate the final management plan.
Inactivated vaccines (DTaP, IPV) are safe and must be administered. Live-attenuated vaccines (MMR, varicella) are absolutely contraindicated due to severe immunosuppression. No developmental referral is needed.
This provides optimal disease protection without risking disseminated vaccine-strain infection, while correctly addressing developmental progress.

Key Concept

Live-attenuated vaccines (MMR, Varicella) are contraindicated in HIV-infected children aged 1-5 years with severe immunosuppression, defined as a CD4 count <500 cells/mm³ or CD4 <15%.
Question 92Question →

Match each pediatric patient's clinical presentation or medical history with the most appropriate vaccine management decision.

Click a left item, then click its matching right item

Items

A 4-month-old infant presenting for well-child care with a history of surgically reduced intussusception.
A 15-month-old child presenting for well-child care who is currently receiving maintenance chemotherapy for acute lymphoblastic leukemia.
A 9-month-old infant presenting prior to international travel to an area with endemic measles.
A 12-month-old child with a history of anaphylaxis to eggs presenting for an initial influenza vaccination.
A term newborn delivered in the hospital to a mother with a documented positive hepatitis B surface antigen (HBsAg) test.

Matches

Show answer & explanation

Answer

The correct matches pair the infant with intussusception to the rotavirus vaccine contraindication; the child on chemotherapy to the live-attenuated vaccine contraindication; the 9-month-old traveler to early MMR vaccination; the child with an egg allergy to routine influenza vaccination; and the newborn of an HBsAg-positive mother to immediate active and passive HepB immunization.
The correct pairings accurately reflect current evidence-based immunization guidelines. A history of intussusception specifically contraindicates the rotavirus vaccine due to recurrence risk. Severe immunocompromise (e.g., active chemotherapy) universally contraindicates all live-attenuated vaccines. Infants between 6 and 11 months traveling internationally should receive an early MMR dose to provide temporary protection, though it does not count toward the routine series. An egg allergy is no longer a contraindication to the influenza vaccine. Newborns of HBsAg-positive mothers require both the HepB vaccine and HBIG within 12 hours of birth.

Step-by-Step Solution

1
Analyze the first patient's history (intussusception) to determine specific vaccine contraindications.
The rotavirus vaccine is strictly contraindicated.
There is a small risk of recurrent intussusception associated with the administration of this specific vaccine.
2
Analyze the second patient's immune status (chemotherapy) to determine vaccine safety.
All live-attenuated vaccines are contraindicated.
Severe immunocompromise places the patient at high risk for disseminated infection from live vaccine strains.
3
Analyze the third patient's travel risk (endemic measles at 9 months of age) against current schedules.
An early MMR vaccine dose is indicated.
Infants aged 6-11 months require protection before international travel, but doses administered before 12 months of age do not count toward the routine childhood series.
4
Analyze the fourth patient's allergy history (egg anaphylaxis) against current influenza vaccine guidelines.
The influenza vaccination can proceed normally.
Current medical guidelines dictate that egg allergy, regardless of severity, is no longer a contraindication to the flu vaccine.
5
Analyze the newborn's maternal exposure (HBsAg positive) to determine the required post-exposure prophylaxis.
Active and passive HepB immunoprophylaxis is required immediately.
The hepatitis B vaccine and hepatitis B immune globulin must both be administered within 12 hours of birth to successfully prevent vertical transmission of the virus.

Key Concept

Specific vaccine contraindications, precautions, and indications based on pediatric patient medical history, including immunodeficiency, anatomical history, severe allergies, travel, and maternal exposures.
Question 93Question →

A primary care network is developing an automated electronic medical record system to alert pediatricians about critical immunization milestones. Arrange the following immunization-related events in chronological order from the earliest age to the oldest age at which they are typically recommended to occur for a healthy pediatric patient following the standard CDC schedule.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence from earliest to oldest is: 1) Maximum age limit for the rotavirus vaccine, 2) First routine MMR vaccine, 3) Final routine early childhood IPV, 4) Adolescent Tdap booster, 5) MenACWY booster.
The correct chronological sequence aligns perfectly with the CDC harmonized immunization schedule. The maximum age for the rotavirus vaccine (8 months) is followed by the first MMR dose (12-15 months). The pre-school IPV booster is given next (4-6 years), followed by the adolescent Tdap booster (11-12 years), and finally the MenACWY booster (16 years).

Step-by-Step Solution

1
Identify the timing for the rotavirus vaccine series completion.
The strict maximum age limit for the final dose is 8 months, 0 days.
Due to an increased risk of intussusception in older infants, the rotavirus series must be strictly completed before 8 months of age.
2
Identify the timing for the first routine administration of the MMR vaccine.
The first dose of the MMR vaccine is routinely given between 12 and 15 months of age.
Live attenuated vaccines like MMR are generally delayed until at least 12 months of age to prevent interference from circulating maternal antibodies, ensuring a robust immune response.
3
Identify the timing for the final early childhood dose of the inactivated poliovirus vaccine (IPV).
The final dose of the primary IPV series is administered between 4 and 6 years of age.
This dose serves as a booster prior to elementary school entry to ensure durable immunity against poliomyelitis.
4
Identify the timing for the routine adolescent Tdap booster.
The Tdap booster is routinely administered at 11 to 12 years of age.
Because pertussis immunity wanes after the childhood DTaP series (which is completed at 4-6 years), adolescents require a reduced-dose Tdap booster.
5
Identify the timing for the booster dose of the quadrivalent meningococcal conjugate vaccine (MenACWY).
The MenACWY booster is administered at 16 years of age.
While the primary dose is given at 11-12 years, a booster is required at 16 years to maintain protective antibody titers during late adolescence, which is the peak age of risk for meningococcal disease.

Key Concept

The routine pediatric immunization schedule spans from birth through adolescence, requiring strict adherence to age-specific milestones including maximum age limits (rotavirus at 8 months), live vaccine initiation (MMR at 12-15 months), pre-school boosters (IPV at 4-6 years), and adolescent boosters (Tdap at 11-12 years, MenACWY at 16 years).
Question 94Question →

A 4-year-old boy is brought to the clinic for a routine health maintenance evaluation. He was born at 39 weeks gestation via uncomplicated spontaneous vaginal delivery. Four weeks ago, he was diagnosed with minimal change disease and was started on oral prednisone at 2 mg/kg/day. He has been taking the medication continuously since then with significant improvement in his edema. His mother brings up a concern regarding his development; she notes that he can hop on one foot, copy a cross, and play cooperatively with other children, but he is unable to skip on one foot or tie his shoelaces. Vital signs today are within normal limits for his age. Physical examination reveals mild cushingoid features but is otherwise unremarkable. A review of his immunization record shows he received all recommended vaccines up to age 2 years. He is currently scheduled to receive his standard kindergarten booster vaccines. Which of the following is the most appropriate management for this patient today?

Show answer & explanation

Answer: Provide diphtheria, tetanus, and acellular pertussis (DTaP) and inactivated poliovirus (IPV) vaccines only; provide developmental reassurance

Answer

Provide diphtheria, tetanus, and acellular pertussis (DTaP) and inactivated poliovirus (IPV) vaccines only; provide developmental reassurance
The correct management is to administer only the inactivated vaccines (DTaP and IPV) and reassure the mother regarding the child's development. This patient is receiving high-dose systemic corticosteroids (prednisone at ≥\ge 2 mg/kg/day for ≥\ge 14 consecutive days), which induces profound immunosuppression. Under these conditions, live-attenuated vaccines, such as MMR and varicella, are strictly contraindicated due to the risk of vaccine-strain infection. These live vaccines should be deferred until the patient has been off high-dose steroids for at least 1 month. Conversely, inactivated vaccines (such as DTaP and IPV) are safe and should be administered according to the schedule, even though the immune response may be blunted. Regarding development, a healthy 4-year-old is expected to hop on one foot, copy a cross, and play cooperatively. The abilities to skip on alternate feet and tie shoelaces typically emerge around age 5. Therefore, the child is meeting appropriate milestones, and the mother should simply be reassured.

Step-by-Step Solution

1
Assess the patient's immune status based on current medications.
The patient is on high-dose systemic corticosteroids (2 mg/kg/day of prednisone for >14 days).
High-dose steroid therapy causes significant immunosuppression, altering standard vaccine safety protocols.
2
Determine which of the scheduled vaccines can be safely administered.
DTaP and IPV are inactivated and can be given. MMR and Varicella are live-attenuated and must be deferred.
Live-attenuated vaccines are strictly contraindicated in severely immunocompromised patients due to the risk of uncontrolled viral replication.
3
Evaluate the mother's developmental concerns against age-appropriate milestones.
Hopping on one foot and copying a cross are normal 4-year-old milestones. Skipping and tying shoelaces are expected at age 5.
Identifying that the child's development is entirely normal indicates that reassurance, rather than referral, is the correct action.

Key Concept

Immunization contraindications in immunocompromised pediatric patients and normal preschool developmental milestones.
Question 95Question →

A 2-month-old girl is brought to the clinic for a routine well-child visit. She was born at 39 weeks gestation via uncomplicated vaginal delivery. Her mother has severe Crohn disease and was treated with infliximab throughout the pregnancy. The infant is exclusively breastfed, feeds well, and is gaining weight appropriately. Her physical examination is unremarkable. She received the hepatitis B vaccine at birth. The pediatrician discusses the routine 2-month immunizations, which normally include the diphtheria, tetanus, and acellular pertussis (DTaP); Haemophilus influenzae type b (Hib); inactivated poliovirus (IPV); pneumococcal conjugate (PCV); and rotavirus vaccines. Based on this patient's history, which of the following is the most appropriate recommendation regarding her immunizations today?

Show answer & explanation

Answer: Withhold the rotavirus vaccine and administer the remaining routine vaccines.

Answer

Withhold the rotavirus vaccine and administer the remaining routine vaccines.
The correct recommendation is to withhold the rotavirus vaccine and administer all other routine 2-month vaccines. Infliximab is an IgG1 monoclonal antibody that actively crosses the placenta, particularly in the third trimester. Consequently, infants born to mothers receiving this biologic therapy are born with therapeutic serum levels of the drug, rendering them functionally immunocompromised for up to 6 months of age. According to the CDC, live-attenuated vaccines are contraindicated in these infants during this 6-month window due to the risk of uncontrolled vaccine-strain viral replication. Of the routine 2-month immunizations, only the rotavirus vaccine is live-attenuated. The other scheduled vaccines (DTaP, Hib, IPV, and PCV) are inactivated and are safe and highly recommended to prevent life-threatening childhood illnesses.

Step-by-Step Solution

1
Identify the maternal medication and its pharmacokinetic properties during pregnancy.
The mother took infliximab, an IgG1 monoclonal antibody targeting TNF-alpha.
IgG antibodies actively cross the placenta, primarily during the third trimester, providing passive immunity but also transferring any IgG-based medications.
2
Determine the clinical implication for the infant.
The infant is considered functionally immunocompromised.
Because infliximab crosses the placenta, the infant can have detectable serum levels of the immunosuppressive drug for up to 6 months after birth.
3
Apply general immunization guidelines for immunocompromised patients.
Live-attenuated vaccines are strictly contraindicated.
Immunocompromised individuals lack the cellular immunity to control live-attenuated viruses, placing them at risk for disseminated vaccine-strain infection.
4
Evaluate the standard 2-month vaccine schedule to identify any live vaccines.
Rotavirus is the only live vaccine on the 2-month schedule.
DTaP, Hib, IPV, and PCV are all inactivated, toxoid, or recombinant subunit vaccines and are safe to administer.
5
Formulate the final management plan.
Withhold the rotavirus vaccine, but give DTaP, Hib, IPV, and PCV.
Inactivated vaccines are safe and essential for protecting the vulnerable infant, while the live rotavirus vaccine poses a life-threatening risk.

Key Concept

Infants exposed to maternal immunosuppressive biologics (like TNF-alpha inhibitors) in utero are considered immunocompromised for the first 6 months of life, making early live vaccines (e.g., rotavirus) contraindicated.
Question 96Question →

During routine pediatric well-child visits, physicians must provide evidence-based anticipatory guidance regarding infant nutrition. Proper timing of dietary transitions is critical to support growth and prevent nutrient deficiencies or developmental issues. Arrange the following nutritional interventions in the correct chronological order of their typical implementation for a healthy term infant, from the earliest age to the latest age.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological order is: 1) Initiation of oral vitamin D supplementation (shortly after birth), 2) Introduction of complementary solid foods (4 to 6 months), 3) Introduction of whole cow's milk (12 months), 4) Complete discontinuation of bottle-feeding (15 to 18 months), and 5) Transition from whole cow's milk to low-fat milk (24 months).
The American Academy of Pediatrics (AAP) provides a strict chronological framework for infant nutrition to support optimal development and prevent disease. Vitamin D is required starting in the first few days of life for breastfed infants to prevent rickets. Complementary solid foods are introduced at 4 to 6 months to meet increasing iron demands and match the infant's loss of the extrusion reflex. Whole cow's milk is strictly delayed until 12 months to prevent occult intestinal bleeding and iron deficiency anemia. Bottle weaning should begin at 12 months and be completed by 15 to 18 months to prevent dental caries. Finally, the transition to low-fat milk occurs at 24 months, marking the end of the critical period for high-fat dependent brain myelination.

Step-by-Step Solution

1
Identify the nutritional intervention required immediately after birth.
Initiation of 400 IU daily oral vitamin D supplementation.
Exclusively breastfed infants are at risk for vitamin D deficiency; supplementation must begin within the first few days of life.
2
Identify the age for introducing solid foods.
Introduction of complementary solid foods at 4 to 6 months.
By 4 to 6 months, fetal iron stores are depleted, and the infant demonstrates the motor skills required to safely swallow purees.
3
Determine when whole cow's milk can be safely given.
Introduction of whole cow's milk at 12 months.
Before 1 year of age, cow's milk increases the risk of iron deficiency anemia due to its low iron content, poor iron bioavailability, and potential to cause microscopic intestinal blood loss.
4
Identify the timeline for weaning off the bottle.
Complete discontinuation of bottle-feeding by 15 to 18 months.
Prolonged bottle use is highly associated with early childhood dental caries and overconsumption of milk, which can displace iron-rich solid foods.
5
Identify when dietary fat should be restricted.
Transition to low-fat (1% or 2%) cow's milk at 24 months (2 years).
Infants require the dense fat and cholesterol found in whole milk to support rapid neurological development and myelination until 2 years of age.

Key Concept

Pediatric Nutritional Anticipatory Guidance
Question 97Question →

A 15-month-old boy is brought to the clinic for a routine well-child visit. He has not received any immunizations since his 6-month well-child visit due to missed appointments. Five months ago, he was hospitalized for 5 days and successfully treated with high-dose intravenous immunoglobulin (IVIG) and aspirin for Kawasaki disease. He currently takes no medications and has no other medical conditions. His parents express concern because he is not yet running or speaking in two-word phrases. He currently walks independently, drinks from a cup, and says three specific words other than "mama" and "dada". Vital signs are within normal limits, and physical examination shows no abnormalities. Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Reassure the parents regarding development, administer indicated inactivated vaccines, and defer live-attenuated vaccines.

Answer

Reassure the parents regarding development, administer indicated inactivated vaccines, and defer live-attenuated vaccines.
The correct approach is to reassure the parents about their child's development and administer only inactivated vaccines while deferring live-attenuated vaccines. At 15 months of age, walking independently and speaking 3 to 5 words is developmentally normal. The skills the parents are concerned about—running and speaking in two-word phrases—are milestones that are typically achieved by 24 months of age, so a developmental referral is not indicated. Furthermore, this patient requires catch-up immunizations. Because he received high-dose IVIG for Kawasaki disease 5 months ago, passively acquired antibodies are still present in his circulation. These antibodies can neutralize live-attenuated viruses (such as the measles, mumps, rubella, and varicella vaccines), rendering the vaccines ineffective. Therefore, live-attenuated vaccines must be deferred for a total of 11 months following high-dose IVIG therapy. In contrast, IVIG does not interfere with the immune response to inactivated vaccines (such as DTaP, Hib, PCV, HepA, and IPV), which should be administered immediately to provide timely protection.

Step-by-Step Solution

1
Evaluate the child's developmental milestones based on parental concerns.
The child walks independently, drinks from a cup, and speaks 3-5 words, which aligns with normal 15-month milestones. Running and two-word phrases are 24-month milestones.
To determine if the parental concern warrants a referral for developmental delay or simple reassurance.
2
Assess the appropriate immunization schedule in the context of recent high-dose IVIG therapy.
Inactivated vaccines can be safely administered, but live-attenuated vaccines must be deferred.
High-dose IVIG contains circulating antibodies that can neutralize live vaccine viruses (such as MMR and Varicella) for up to 11 months, rendering them ineffective. IVIG does not impact the efficacy of inactivated vaccines.

Key Concept

High-dose IVIG therapy requires delaying the administration of live-attenuated vaccines for up to 11 months due to antibody interference, whereas inactivated vaccines can be given on their normal schedule. Running and speaking in two-word phrases are normal 24-month milestones, not expected at 15 months.
Estimated Time:1m 0s
Question 98Question →

A pediatric clinic is establishing a new electronic medical record protocol that automatically prompts physicians to order specific universal screening tests during well-child visits. The clinic director wants to ensure the prompts appear at the correct milestone visits for healthy, asymptomatic children with no known risk factors. Arrange the following universal screening interventions in chronological order according to the earliest age at which the system should first prompt the physician to perform them.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: Autism screening (18 months), Blood pressure measurement (3 years), Dyslipidemia screening (9 to 11 years), Depression screening (12 years), and HIV screening (15 to 18 years).
The American Academy of Pediatrics (AAP) Bright Futures guidelines establish a standardized timeline for universal screening in asymptomatic children to detect conditions early. The exact chronological onset for these universal screenings is: autism spectrum disorder (18 months), blood pressure (3 years), dyslipidemia (9 to 11 years), major depressive disorder (12 years), and human immunodeficiency virus (15 to 18 years).

Step-by-Step Solution

1
Determine the earliest recommended age for autism spectrum disorder screening.
18 months.
The American Academy of Pediatrics recommends universal screening for autism at the 18-month and 24-month well-child visits.
2
Identify the onset age for routine blood pressure measurement.
3 years.
Universal blood pressure screening begins at age 3 and continues annually.
3
Establish the timeframe for universal dyslipidemia screening.
9 to 11 years.
A universal lipid profile is drawn once between ages 9 and 11, prior to the physiological lipid changes associated with puberty.
4
Recall the starting age for universal depression screening.
12 years.
Annual screening for major depressive disorder begins universally at age 12.
5
Determine the age range for universal HIV screening.
15 to 18 years.
Routine HIV screening is recommended at least once between the ages of 15 and 18, reflecting the onset of sexual activity and other risks in adolescence.

Key Concept

Chronology of universal pediatric preventive care and screening guidelines.
Estimated Time:1m 30s
Question 99Question →

A couple brings their 18-month-old son to the pediatrician for a scheduled health maintenance visit. The parents express concern that their son might be developmentally delayed. They note that he does not yet use 2-word sentences, cannot build a tower of 6 cubes, and is unable to walk up the stairs by alternating his feet. Currently, the boy runs, walks up the stairs with one hand held while placing both feet on each step, builds a tower of 3 cubes, and uses 15 individual words. He feeds himself with a spoon and enjoys playing pretend. His past medical history is unremarkable, and his vital signs are within normal limits. The boy missed his 15-month visit and is due for routine immunizations, which include the diphtheria, tetanus, and acellular pertussis (DTaP); measles, mumps, and rubella (MMR); and varicella vaccines. The child's father recently underwent a renal transplant and is currently taking mycophenolate mofetil and tacrolimus. The parents ask if it is safe to give the child his scheduled vaccines given his father's immunosuppressed status. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Reassure the parents regarding his development and administer all recommended vaccines today

Answer

Reassure the parents regarding his development and administer all recommended vaccines today
The correct management is to reassure the parents regarding his development and administer all recommended vaccines today. This patient's developmental milestones (running, walking up stairs with assistance, building a 3-cube tower, speaking 15 words, playing pretend) are completely normal for an 18-month-old. The parents' expectations reflect milestones appropriate for older children (2-word phrases and a 6-cube tower are expected at 24 months; alternating feet on stairs is expected at 36 months). Therefore, no developmental referral is needed. Regarding immunizations, the administration of live-attenuated vaccines (such as MMR and varicella) is highly recommended for healthy immunocompetent individuals who live with immunosuppressed patients (such as his father, who is taking antirejection medications). Vaccinating household contacts protects the vulnerable patient from exposure to wild-type viruses. The MMR vaccine virus does not transmit to contacts. While the varicella vaccine virus has a very rare risk of transmission, vaccination is still recommended; isolation is only advised if the vaccinated child subsequently develops a rash.

Step-by-Step Solution

1
Evaluate the child's developmental milestones against age-appropriate expectations.
The child runs, walks up stairs with help, builds a 3-cube tower, uses 15 words, and plays pretend. These perfectly align with normal 18-month milestones. The milestones the parents are expecting (2-word phrases, 6-cube tower, alternating feet on stairs) are expected at 24 to 36 months.
Accurate assessment of milestones is necessary to determine if a referral for early intervention is warranted.
2
Determine the safety and indication for administering live-attenuated vaccines (MMR, Varicella) to a household contact of an immunocompromised person.
Healthy household contacts of immunosuppressed patients (such as solid organ transplant recipients) should receive all routine live and inactivated vaccines.
Vaccinating healthy household contacts creates a protective 'cocoon' around the immunosuppressed individual, preventing wild-type infections from being introduced into the home. There is no risk of transmitting the MMR vaccine virus, and the risk of varicella transmission is negligible unless a rash develops.
3
Synthesize the developmental and immunization assessments into a comprehensive management plan.
The correct management is to provide reassurance that development is on track and to administer all scheduled vaccines without requiring isolation.
This addresses both parental concerns using evidence-based pediatric guidelines.

Key Concept

Immunocompetent children living with immunocompromised household members should receive all routine immunizations, including live-attenuated vaccines like MMR and varicella, to protect the vulnerable household contact.
Question 100Question →

A 5-year-old boy is brought to the clinic by his parents for a routine health maintenance visit prior to starting kindergarten. He was born at 39 weeks gestation via uncomplicated spontaneous vaginal delivery. Vital signs include temperature 37.1°C (98.8°F), heart rate 95/min, and blood pressure 92/58 mm Hg. Physical examination reveals a cooperative, healthy-appearing child. His parents report that they recently immigrated, and his last well-child visit was at age 4 months. He is significantly behind on his immunizations, and a catch-up schedule is initiated today. The physician also reviews the boy's developmental history, and the parents recall his past progress clearly. Arrange the following developmental milestones in the expected chronological order of their acquisition in a normally developing child, from earliest to latest.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The milestones emerge chronologically as follows: Sitting without support (6 months), Utilizing a two-finger pincer grasp (12 months), Kicking a ball forward (2 years), Copying a circle (3 years), and Skipping on alternating feet (5 years).
Developmental milestones are evaluated during pediatric preventive care visits to ensure normal progression. The sequence begins in infancy with sitting without support (6 months), progresses to fine motor dexterity with a neat two-finger pincer grasp (12 months), advances to early toddler gross motor skills like kicking a ball (2 years), continues with fine motor coordination such as copying a circle (3 years), and culminates in advanced gross motor coordination like skipping (5 years).

Step-by-Step Solution

1
Determine the age of expected acquisition for sitting without support.
6 months
Infants typically develop the core strength to sit up without propping by 6 months of age.
2
Determine the age of expected acquisition for utilizing a two-finger pincer grasp.
12 months
Fine motor skills progress from a raking grasp at 6 months to a neat, two-finger pincer grasp by 12 months.
3
Determine the age of expected acquisition for kicking a ball forward.
24 months (2 years)
Toddlers refine their balance and coordination to kick a ball and walk up stairs one step at a time by 2 years of age.
4
Determine the age of expected acquisition for copying a circle.
36 months (3 years)
Fine motor skills advance to drawing simple shapes, with a circle typically mastered at 3 years of age.
5
Determine the age of expected acquisition for skipping on alternating feet.
60 months (5 years)
Complex gross motor coordination, such as skipping and catching a bounced ball, is typically achieved by 5 years of age.

Key Concept

Normal pediatric developmental milestones follow a predictable chronological sequence and are evaluated alongside immunizations during well-child visits to identify any neurological or physical delays.
PreviousPage 5 / 6Next
Preventive Care and Immunizations Practice Questions — USMLE Step 2 CK — Page 5 | Examkin